NASDAQ:OMGA • US68217N1054
Past quarterly earnings results for OMEGA THERAPEUTICS INC (OMGA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | -0.30 | -0.28 | -6.31% | 25.00% | 2.612M | 1.265M | 106.48% | 214.32% |
| Q2 2024 | -0.30 | -0.37 | 19.51% | 44.44% | 2.134M | 967.98K | 120.46% | 181.16% |
| Q1 2024 | -0.36 | -0.34 | -5.88% | 28.00% | 2.36M | 1.663M | 41.91% | 357.36% |
| Q4 2023 | -0.37 | -0.46 | 19.12% | 42.19% | 989K | 581.4K | 70.11% | 33.65% |
| Q3 2023 | -0.40 | -0.54 | 25.81% | 25.93% | 831K | 459K | 81.05% | 38.50% |
| Q2 2023 | -0.54 | -0.52 | -4.39% | - | 759K | 459K | 65.36% | 58.13% |
| Q1 2023 | -0.50 | -0.61 | 17.83% | -19.05% | 516K | 263.497K | 95.83% | 91.11% |
| Q4 2022 | -0.64 | -0.64 | 0.40% | -45.45% | 740K | 262.65K | 181.74% | - |
| Q3 2022 | -0.54 | -0.63 | 14.06% | 5.26% | 600K | 103.224K | 481.26% | - |
| Q2 2022 | -0.54 | -0.53 | -2.30% | 83.93% | 480K | 52.53K | 813.76% | - |
| Q1 2022 | -0.42 | -0.58 | 27.44% | - | 270K | - | - | |
| Q4 2021 | -0.44 | -0.54 | 18.61% | - | - | - | ||
| Q3 2021 | -0.57 | -0.49 | -16.42% | - | - | - | ||
| Q2 2021 | -3.36 | -1.23 | -172.24% | - | - | - | ||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
OMEGA THERAPEUTICS INC (OMGA) last reported earnings on 3/6/2025.
OMEGA THERAPEUTICS INC (OMGA) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, OMEGA THERAPEUTICS INC (OMGA) has beaten EPS estimates in 2 out of 4 releases.